Investor Relations

A leadership story in the field of advanced cell therapy

Investor Relations

Investor FAQs

Investor FAQs

Vericel Corporation Stock is traded on the Nasdaq Capital Market. The symbol is VCEL.

Headquarters:
Vericel Corporation
64 Sidney Street
Cambridge, MA 02139
Phone: (617) 252-7999
Fax: (617) 252-7555

Click here for full contact information.

Vericel Corporation does not currently offer a direct stock purchase program.

Vericel Corporation does not currently pay dividends.

Registrar and Transfer Agent
Continental Stock Transfer & Trust Company
17 Battery Place, 8th Floor
New York, NY 10004
Phone: (212) 509-4000

Vericel Corporation's fiscal year begins on January 1 and ends on December 31.

Auditors
PricewaterhouseCoopers LLP
225 South Sixth Street, Suite 1400
Minneapolis, MN 55402
Phone: (612) 596-6000

Day High:
Day Low:
Volume:
on
Copyright West LLC. Minimum 15 minutes delayed.